Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
970 stocks in the US match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Healthcare | $2.28B | $25.89 | −45.67% | −3.93% |
| NEO | NeoGenomics, Inc. | Healthcare | $2.26B | $17.37 | −0.46% | +29.63% |
| CLOV | Clover Health Investments, Corp. | Healthcare | $2.26B | $4.25 | −23.97% | −1.96% |
| ADUS | Addus HomeCare Corporation | Healthcare | $2.25B | $120.71 | −3.00% | +1.25% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| URGN | UroGen Pharma Ltd. | Healthcare | $2.25B | $45.94 | −9.58% | +12.38% |
| PVLA | Palvella Therapeutics, Inc. | Healthcare | $2.22B | $154.33 | −4.37% | +8.04% |
| MD | Pediatrix Medical Group, Inc. | Healthcare | $2.19B | $26.95 | −3.54% | +0.34% |
| XRAY | DENTSPLY SIRONA Inc. | Healthcare | $2.18B | $10.93 | −26.45% | −18.98% |
| VCEL | Vericel Corporation | Healthcare | $2.17B | $42.44 | −13.95% | −9.14% |
| ADMA | ADMA Biologics, Inc. | Healthcare | $2.16B | $9.63 | −52.93% | +9.56% |
| ZBIO | Zenas BioPharma, Inc. | Healthcare | $2.15B | $33.04 | −25.92% | +2.32% |
| ESTA | Establishment Labs Holdings Inc. | Healthcare | $2.15B | $72.45 | −25.76% | −21.16% |
| CLOV34.SA | Clover Health Investments, Corp. | Healthcare | $2.15B | 20.84 BRL | −25.97% | −7.01% |
| STOK | Stoke Therapeutics, Inc. | Healthcare | $2.14B | $33.09 | −17.73% | +12.59% |
| XNCR | Xencor, Inc. Common Stock | Healthcare | $2.11B | $28.44 | −7.09% | +42.41% |
| ZYME | Zymeworks Inc. | Healthcare | $2.10B | $29.31 | −4.29% | +29.61% |
| GENB | Generate Biomedicines, Inc. | Healthcare | $2.07B | $16.14 | −28.80% | +22.83% |
| SRPT | Sarepta Therapeutics, Inc. | Healthcare | $2.06B | $19.46 | −23.14% | +26.12% |
| SEM | Select Medical Holdings Corp | Healthcare | $2.05B | $16.51 | −2.83% | −0.12% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | Healthcare | $2.03B | $33.99 | −26.11% | −5.56% |
| PIII | P3 Health Partners Inc. | Healthcare | $1.98B | $9.92 | −41.27% | −5.70% |
| PGNY | Progyny, Inc. | Healthcare | $1.98B | $26.37 | −20.25% | −14.27% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | Healthcare | $1.98B | 4.82 BRL | −27.74% | +24.55% |
| TSHA | Taysha Gene Therapies, Inc. | Healthcare | $1.96B | $6.02 | −17.53% | +10.26% |
| ASTH | Astrana Health, Inc. | Healthcare | $1.92B | $38.61 | −25.17% | +1.69% |
| SNDA | Sonida Senior Living, Inc. | Healthcare | $1.91B | $39.67 | −10.63% | −7.89% |
| NTLA | Intellia Therapeutics, Inc. | Healthcare | $1.89B | $13.19 | −53.31% | +21.12% |
| DMRA | Damora Therapeutics, Inc. | Healthcare | $1.89B | $30.39 | −20.70% | +3.30% |
| SEPN | Septerna, Inc. | Healthcare | $1.88B | $40.25 | −21.23% | +18.49% |
| VIR | Vir Biotechnology, Inc. | Healthcare | $1.87B | $11.08 | −4.97% | +25.20% |
| RXRX | Recursion Pharmaceuticals, Inc. | Healthcare | $1.87B | $3.49 | −51.39% | +14.43% |
| SGRY | Surgery Partners, Inc. | Healthcare | $1.84B | $14.04 | −40.98% | −9.88% |
| PSNL | Personalis, Inc. | Healthcare | $1.82B | $17.08 | −9.58% | +43.77% |
| BLFS | BioLife Solutions, Inc. | Healthcare | $1.82B | $37.00 | −2.89% | +15.70% |
| INBX | Inhibrx Biosciences, Inc. | Healthcare | $1.81B | $125.34 | −19.29% | +57.30% |
| LMAT | LeMaitre Vascular, Inc. | Healthcare | $1.81B | $79.61 | −32.54% | −22.18% |
| ETON | Eton Pharmaceuticals, Inc. | Healthcare | $1.79B | $62.62 | −5.65% | +34.20% |
| INSP | Inspire Medical Systems, Inc. | Healthcare | $1.79B | $61.80 | −57.97% | +18.91% |
| SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | $1.77B | $20.09 | −21.49% | +2.34% |
| FTRE | Fortrea Holdings Inc. | Healthcare | $1.76B | $18.53 | −13.37% | −10.48% |
| ANAB | AnaptysBio, Inc. | Healthcare | $1.73B | $58.00 | −19.85% | +11.30% |
| ANIP | ANI Pharmaceuticals, Inc. | Healthcare | $1.71B | $74.56 | −25.07% | −8.00% |
| MAZE | Maze Therapeutics, Inc. | Healthcare | $1.69B | $29.58 | −44.86% | +6.10% |
| AVLN | Avalyn Pharma Inc. | Healthcare | $1.64B | $37.04 | −7.79% | +33.29% |
| BCAX | Bicara Therapeutics Inc. | Healthcare | $1.64B | $24.73 | −20.20% | −8.00% |
| FBRX | Forte Biosciences, Inc. | Healthcare | $1.63B | $76.99 | −0.27% | +0.44% |
| AGL | agilon health, inc. | Healthcare | $1.61B | $95.74 | −28.04% | −3.43% |
| ARDT | Ardent Health, Inc. | Healthcare | $1.58B | $11.23 | −27.45% | −2.09% |
| XERS | Xeris Biopharma Holdings, Inc. | Healthcare | $1.58B | $8.68 | −13.89% | +5.34% |
| ABSI | Absci Corporation | Healthcare | $1.58B | $9.22 | −23.52% | +29.31% |
| TRAX | First Tracks Biotherapeutics, Inc. | Healthcare | $1.58B | $44.19 | −11.46% | +5.59% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | Healthcare | $1.58B | 57.60 BRL | −3.92% | +8.15% |
| HCSG | Healthcare Services Group, Inc. | Healthcare | $1.57B | $22.91 | −11.03% | −3.54% |
| TYRA | Tyra Biosciences, Inc. | Healthcare | $1.56B | $26.22 | −35.50% | −15.09% |
| KMTS | Kestra Medical Technologies, Ltd. | Healthcare | $1.56B | $26.57 | −11.43% | +11.36% |
| LBRX | LB Pharmaceuticals Inc | Healthcare | $1.55B | $48.17 | −3.98% | +37.85% |
| AVBP | ArriVent BioPharma, Inc. | Healthcare | $1.54B | $31.14 | −13.09% | +3.87% |
| CNMD | CONMED Corporation | Healthcare | $1.53B | $50.48 | −10.88% | +14.08% |
| INVA | Innoviva, Inc. | Healthcare | $1.53B | $21.24 | −15.55% | −2.61% |
| OMCL | Omnicell, Inc. | Healthcare | $1.53B | $33.45 | −39.18% | −22.30% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.